News Releases

2008

XXX
Oct.17,2008
Ono Enters into License Agreement with Progenics (81.5KB)
XXX
Oct.01,2008
Announcement on Results of Phase II / III Clinical Study in Japan with Arocyte for Injection for Treatment of Acute Ischemic Stroke (47.9KB)
XXX
Sep.22,2008
Announcement on Completion of Acquisition of the Company's Own Shares (85.7KB)
XXX
Aug.05,2008
Revisions of First Half / Full Year Business Forecasts for FY 2008 (74.3KB)
XXX
Aug.05,2008
Announcement on Changes of Representative Directors and Members of the Board of Directors (121KB)
XXX
Jun.03,2008
Preliminary Data from Ongoing Phase 1 Trial of Investigational Fully Human Anti-PD-1 Antibody “ONO-4538/MDX-1106” Presented at American Society of Clinical Oncology (107KB)
XXX
May.14,2008
Announcement on Changes of Representative Directors and Members of the Board of Directors (115KB)
XXX
May.14,2008
Announcement on Partial Amendments to the Articles of Incorporation (66.0KB)
XXX
May.08,2008
Ono Resolved Increase in Dividends Projected for Fiscal 2007(the 60th Fiscal Term ending on March 31st,2008) (129KB)
XXX
Apr.17,2008
Discontinuation of Development for an Additional Indication of Cervical Spondylosis of Limaprost Alfadex,an Oral Prostaglandin E1 Derivative Preparation (53.0KB)
XXX
Apr.14,2008
Functionality Expansion of Ono Pharma USA, Inc., which is Ono's US Development Base (56.5KB)
XXX
Apr.14,2008
Announcement on Acquisition of the Company's Own Shares (59.9KB)
XXX
Mar.27,2008
Ono Enters into New Fragment-Based Drug Discovery Agreement on a Protease Target with Evotec AG (66.3KB)